Semaglutide: A Promising Ally Against Alzheimer’s?
In a groundbreaking study, researchers at Case Western Reserve School of Medicine have identified a potential new benefit of semaglutide, a widely used diabetes and weight-loss drug. According to their findings, semaglutide may significantly reduce the risk of Alzheimer’s disease in individuals with type 2 diabetes (T2D), outperforming seven other anti-diabetic medications.
Alzheimer’s disease, a devastating brain disorder that erodes memory and cognitive abilities, affects nearly 7 million Americans aged 65 and older, as reported by the Alzheimer’s Association. Alarmingly, it claims more lives annually than breast and prostate cancer combined.
Published in Alzheimer’s & Dementia: The Journal of the Alzheimer’s Association, the study suggests that T2D patients taking semaglutide had a markedly lower risk of developing Alzheimer’s disease. This trend was consistent across various subgroups, regardless of obesity status, gender, or age.
Semaglutide, a glucagon-like peptide receptor (GLP-1R) agonist, is the active ingredient in popular medications like Wegovy and Ozempic. It works by reducing hunger and regulating blood sugar levels in T2D patients.
Under the leadership of Rong Xu, a professor of biomedical informatics, the research team analyzed three years of electronic health records from nearly one million U.S. patients with T2D. Their statistical approach, which mimicked a randomized clinical trial, revealed that patients prescribed semaglutide had a significantly lower risk of Alzheimer’s compared to those on other anti-diabetic medications.
According to the CDC, Alzheimer’s disease results in approximately 120,000 deaths annually, ranking as the seventh-leading cause of death in the United States.
“This new study provides real-world evidence for semaglutide’s potential impact on Alzheimer’s disease,” Xu stated. “While preclinical research has hinted at its protective effects against neurodegeneration and neuroinflammation, our findings suggest the need for further exploration through randomized clinical trials.”
Despite these promising results, the study’s limitations prevent researchers from drawing definitive causal conclusions. Xu emphasized the importance of continued research into semaglutide’s potential as a treatment for this debilitating condition, encouraging further investigation into alternative drugs.
For more information, please contact Patty Zamora at [email protected].
Getting licensed or staying ahead in your career can be a journey—but it doesn’t have to be overwhelming. Grab your favorite coffee or tea, take a moment to relax, and browse through our articles. Whether you’re just starting out or renewing your expertise, we’ve got tips, insights, and advice to keep you moving forward. Here’s to your success—one sip and one step at a time!
A fast‑growing Israeli startup called Agora is reshaping how real estate investment firms operate by replacing outdated spreadsheets and scattered emails with a seamless digital platform. Built by former military intelligence technologists, Agora centralizes investor onboarding, reporting, financial tracking and communication—giving firms a modern backbone for managing complex portfolios. As proptech adoption accelerates worldwide, understanding tools like Agora is becoming essential knowledge for new and seasoned real estate professionals alike.
Canada remains one of the fastest and most accessible places to launch a real estate career, with no university degree required and most provinces offering licensing timelines under a year. This guide breaks down every major step—eligibility, education, exams, brokerage registration, and income expectations—while comparing requirements across Ontario, BC, Alberta, and Quebec. It also highlights what truly separates successful agents from those who leave the profession: consistent prospecting, strong preparation, and long-term discipline.
The 2026 housing market is starting off with colder-than-usual activity but warmer opportunities for buyers. Mortgage rates have dipped nearly a full percentage point from last year, inventory is slowly increasing, and competition is easing just enough to give buyers more leverage. While prices are still rising, the pace has cooled, and motivated sellers are becoming more flexible. Whether you're planning to buy or preparing clients as a real estate professional, the key message remains the same: the right time to purchase depends far more on your financial readiness than on headline noise.
More landlords than ever are turning to LLCs to protect their assets, streamline operations, and unlock tax advantages. An LLC can separate your personal finances from your rental business, provide liability protection, and offer valuable tax benefits. This article breaks down what LLCs do for landlords, how they affect taxes, the benefits they bring, and the best practices for setting one up in 2025—giving real estate professionals and investors a clear, practical guide for making the right decision.
Florida lawmakers have approved Sen. Joe Gruters proposal to push more commercial properties from Citizens Property Insurance into the private market. The bill tightens eligibility rules, expands the clearinghouse process, and could shift about 25 billion dollars in risk to private carriers. Supporters say the change reduces taxpayer exposure after major storms, while opponents worry about relying more on the less-regulated surplus lines market. The measure now heads to Gov. Ron DeSantis for final approval.
Wire fraud has evolved into a major danger for Florida real estate transactions, with criminals hijacking email accounts, impersonating buyers and sellers, and creating fake title company websites. First‑time buyers are especially vulnerable, and losses often occur right before closing when emotions are high. Experts warn that nearly all wire fraud can be prevented with proper verification, secure communication, and professional training—making education a critical defense for today’s real estate professionals.
